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The long-held view that gamma delta (γδ) T cells in mice and hu-
mans are fundamentally dissimilar, as are γδ cells in blood and
peripheral tissues, has been challenged by emerging evidence of
the cells’ regulation by butyrophilin (BTN) and butyrophilin-like
(BTNL) molecules. Thus, murine Btnl1 and the related gene, Skint1,
mediate T cell receptor (TCR)-dependent selection of murine intra-
epithelial γδ T cell repertoires in gut and skin, respectively; BTNL3
and BTNL8 are TCR-dependent regulators of human gut γδ cells; and
BTN3A1 is essential for TCR-dependent activation of human peripheral
blood Vγ9Vδ2+ T cells. However, some observations concerning BTN/
Btnl molecules continue to question the extent of mechanistic conser-
vation. In particular, murine and human gut γδ cell regulation depends
on pairings of Btnl1 and Btnl6 and BTNL3 and BTNL8, respectively,
whereas blood γδ cells are reported to be regulated by BTN3A1 in-
dependent of other BTNs. Addressing this paradox, we show
that BTN3A2 regulates the subcellular localization of BTN3A1,
including functionally important associations with the endo-
plasmic reticulum (ER), and is specifically required for optimal
BTN3A1-mediated activation of Vγ9Vδ2+ T cells. Evidence that
BTNL3/BTNL8 and Btnl1/Btnl6 likewise associate with the ER
reinforces the prospect of broadly conserved mechanisms un-
derpinning the selection and activation of γδ cells in mice and
humans, and in blood and extralymphoid sites.
gamma delta T cells | butyrophilins | endoplasmic reticulum |
zoledronate | evolutionary conservation
Ever since their unanticipated discovery (1, 2), the T cell re-ceptor (TCR) γ and δ chains and the cells that express them
have offered insights into immunology. For example, rather than
focusing on discrete, pathogen-specific epitopes (e.g., peptides), γδ
TCRs collectively respond to highly diverse antigens, ranging from
self-encoded moieties induced by cellular dysregulation through
lipids presented by CD1 to microbial molecular patterns (3, 4).
Conspicuous among these is the response of most human periph-
eral blood Vγ9Vδ2+ T cells to low-molecular-mass “phosphoanti-
gens” (PAgs), including hydroxymethyl but-2-enyl pyrophosphate
(HMBPP), an intermediate in the deoxyxylulose phosphate path-
way in many bacteria and protozoa, and isopentenylpyrophosphate,
an intermediate in the mevalonate pathway employed from bacteria
through to vertebrates and commonly overexpressed by virus-
infected cells or cells transformed by p53 inactivation (5, 6). How
such charged, low-molecular-mass molecules activate signaling
from large, cell-surface TCR complexes is unclear, fueling the
search for a presenting element, akin to CD1.
In that regard, PAg activation of Vγ9Vδ2+ T cells requires
BTN3A1 (7), a member of the butyrophilin (BTN) and BTN-like
(BTNL) family that in humans comprises 11 genes related to
those encoding “B7-superfamily” members, including PD-L1.
The BTN3A1 gene lies close to BTN3A2 and BTN3A3, and all
three encode type 1 transmembrane proteins comprising an Ig
variable (V) and Ig constant (C) region linked via a single pass
transmembrane (TM) domain to an intracellular region that in
BTN3A1 and BTN3A3 includes a B30.2 domain, akin to that
found in many BTN(L) and TRIM proteins (8).
BTN3A1 forms homodimers (9) and was reported to bind PAg
via its extracellular IgV domain, thereby presenting it directly to
the Vγ9Vδ2 TCR (10). However, this mechanism for PAg-
dependent, TCR-mediated γδ cell activation failed to explain
why BTN3A2 seemingly could not present PAg, despite its
identical IgV domain. Moreover, others have reported PAg
binding to the intracellular B30.2 domain, within which histidine
381 appeared particularly important (11–13). Sensing of in-
tracellular PAg levels by BTN3A1 was shown to alter the con-
formation of its B30.2 domain (14, 15), although how this might
trigger Vγ9Vδ2+ T cell activation remains unclear, as the PAg
site can also bind biologically inactive negatively charged mole-
cules (15).
Provocatively, the implication of BTN3A1 in Vγ9Vδ2 T cell ac-
tivation followed the earlier demonstration that the murine Btnl
gene, Skint1, drives the selective development of murine intra-
epidermal Vγ5Vδ1+ T cells (16–18). Furthermore, we recently
showed that murine Btnl1/Btnl6 drive the selective development
of murine intestinal Vγ7+ intraepithelial T cells, whereas human
BTNL3/BTNL8 selectively regulate human gut Vγ4+ T cells (19).
Thus, a general role is emerging for BTN/BTNL in γδ cell biology.
However, the notion of broadly conserved mechanisms of γδ cell
regulation is challenged by the fact that TCR-dependent mouse and
human gut γδ cell regulation requires pairings of proteins encoded
by Btnl1/Btnl6 and BTNL3/BTNL8, respectively, whereas there is
conflicting evidence as to whether Vγ9Vδ2+ T cell regulation by
BTN3A1 also requires BTN3A2 and/or BTN3A3 (7, 10, 13).
Addressing this paradox, our study shows that BTN3A2 regulates
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the subcellular localization of BTN3A1, including association with
the ER, and is essential for the optimal activation of Vγ9Vδ2+
T cells. Likewise, we find that BTNL3/BTNL8 and Btnl1/Btnl6 are
ER-associated. Hence, conserved molecular mechanisms seemingly
underpin the regulation of major γδ cell subsets across mice and
humans, and across blood and extralymphoid tissues.
Results
Vγ9Vδ2 T Cell Activation Requires BTN3A1 and BTN3A2. Human
HEK293T (293T) embryonic kidney epithelial cells readily stimu-
late Vγ9Vδ2+ T cells when pulsed with either HMBPP or
zoledronate (Zol), a clinically used aminobisphosphonate that
induces isopentenylpyrophosphate accumulation by inhibiting
farnesyl pyrophosphate synthase (20). Vγ9Vδ2+ T cell stimu-
lation is routinely assayed by increased surface expression of
CD107a (LAMP-1), reflecting exocytotic degranulation of cy-
tolytic lysosomes (Fig. S1A). Consistent with expression by
many cell types, RNAs for all BTN3A genes were expressed by
293T cells (Fig. S1B), and pan anti-BTN3A antibody (mono-
clonal antibody 20.1), which cannot discriminate among the three
proteins, detected cell surface BTN3A, as it did on peripheral
blood cell subtypes of three healthy donors (Fig. S1 C and D).
To assess the contributions of BTN3A1, BTN3A2, and/or
BTN3A3 with Vγ9Vδ2+ T cell stimulation (Fig. 1A), we generated
293T lines with disruptions of BTN3A1 (CRA1), BTN3A2 (CRA2),
BTN3A3 (CRA3), all three genes (CRA123), and BTN3A2+3A3
(CRA23; Fig. S2A), which we validated by failure to amplify full-
length products of the relevant BTN3A genes (Fig. 1B) and di-
minished anti-BTN3A antibody staining (Fig. S2B). Consistent with
deleting the BTN3A cluster, CRA123 cells also showed disrupted
BTN2A2 expression (Fig. 1B). Control cells (CREV) were trans-
fected with CRISPR (CR)/Cas9 lacking BTN targeting sequences.
The cell lines were pulsed with a dose-range of Zol and
assessed for their activation of Vγ9Vδ2+ T cells. CREV showed
a potency (Emax) of ∼70% of Vγ9Vδ2+ T cells degranulating,
with EC50 of <1 μMZol (Fig. 1C and Fig. S2C). As expected, this
capacity was completely lost from cells with disrupted BTN3A1,
either alone (CRA1) or along with BTN3A2 and BTN3A3
(CRA123) (Fig. 1C and Fig. S2C). Hence, BTN3A1 is, as described,
strictly required for Vγ9Vδ2+ T cell activation (7, 10, 11, 13).
Conspicuously, CRA2 cells that express endogenous BTN3A1 but
lack BTN3A2 also showed impaired activation of Vγ9Vδ2+ T cells
(Fig. 1C and Fig. S2C). Although the EC50 for CRA2 cells was
also ∼1.0 μM Zol, potency was reduced by ∼50%. Moreover,
CRA23 cells that also express BTN3A1 but neither BTN3A2 nor
BTN3A3 did not activate Vγ9Vδ2+ T cells (Fig. 1C and Fig. S2C).
Conversely, CRA3 cells lacking only BTN3A3 functioned
comparably to CREV cells. In sum, the full functional activity
of BTN3A1 required BTN3A2, with some capacity of BTN3A3
to substitute for BTN3A2. This perspective was reinforced by
experiments in which the functional rescue of CRA123 cells by
single BTN3A genes and combinations thereof was attempted
across a range of Zol concentrations. CRA123 cells transfected
with BTN3A2, BTN3A3, or BTN3A2+A3 showed residual func-
tional capacity. Conversely, CRA123 cells rescued with BTN3A1+
3A2 or BTN33A1+3A3 showed EC50 and Emax comparable to
control cells (CREV), whereas cells transfected with only
BTN3A1 showed greatly increased EC50 (Fig. 1D and Fig. S2D).
Thus, BTN3A1 is necessary but insufficient to promote optimal,
Zol-dependent, Vγ9Vδ2+ T cell activation.
BTN3A1 Heteromers. To assess how BTN3A proteins might collab-
orate, we focused on their potential to interact. Because BTN3A1
can homodimerize via its IgC domain (9), we considered that
BTN3A proteins might similarly form heteromers. Indeed, heter-
odimers of BTN3A1 and BTN3A2 produced in high quantities in
insect cells were recently visualized by electron microscopy, al-
though they were not studied in detail (14). Thus, N-terminal
FLAG-tagged BTN3A1 was expressed in CRA123 cells with or
without N-terminal HA-tagged BTN3A2, or HA-3A2ΔIgC that
lacks the IgC domain. Anti-FLAG- and anti-HA-reactive bands of
appropriate molecular mass were detected as input proteins by
Western blotting lysates from singly- and doubly-transfected cells
(Fig. 2A, Left; Hsp90, loading control). Importantly, anti-HA also
detected HA-BTN3A2, but not HA-3A2ΔIgC, in anti-FLAG im-
munoprecipitates of doubly-transfected cells (Fig. 2A, Right). Thus,
BTN3A2 complexed with BTN3A1 in an IgC-dependent manner.
This was further investigated via mass spectrometry. By plotting
protein intensity ratios (Welch Difference) versus log10 sum of
intensities, BTN3A1 was, as expected, the most greatly enriched
high-intensity species in anti-FLAG immunoprecipitates from cells
cotransduced with FLAG-3A1+HA-3A2 versus cells transduced
with empty vector (Fig. 2B). Of note, however, there was stoi-
chiometric enrichment of BTN3A2. Because no other moiety was
likewise enriched, complexes likely reflect direct, 1:1 interactions of
BTN3A1 and BTN3A2, without stoichiometric mediation by a third
party, consistent with the visualization of complexes obtained using
purified BTN3A1 and BTN3A2 proteins (14).
BTN3A3 could also be coimmunoprecipitated with BTN3A1
(Fig. S3A), consistent with its potential to functionally collaborate
with BTN3A1 in the absence of BTN3A2 (Fig. 1D). However,
BTN3A1 did not coimmunoprecipitate HA-BTNL8, which
coregulates human gut γδ cells, together with BTNL3 (Fig. S3B).
Indeed, FLAG-BTNL3 coimmunoprecipitated HA-BTNL8, but
not HA-BTN3A2 or HA-BTN3A3. Mass spectrometry revealed
statistically significant coenrichment of BTNL3+8 in anti-FLAG
BTNL3 immunoprecipitates, again without obvious coenrichment
of a third party (Fig. 2B and Fig. S3C). Thus, BTN3A1+3A2 and
BTNL3+L8, respectively, form complexes with shared features.
Coregulation of Cell Localization. Next, we used flow cytometry to
assess how the potential to form complexes might regulate
BTN3A1. When CRA123 cells were transfected with the corre-
sponding genes upstream of an internal ribosome entry site
(IRES)-GFP reporter, GFP fluorescence intensity was largely
proportional to total protein levels of each BTN3A gene product,
as measured 24 h posttransfection by flow cytometry of per-
meabilized cells (Fig. S4A). However, nonpermeabilized BTN3A1-
transfected cells lacked such proportionality, whether measured
at 12, 24, or 48 h posttransfection; indeed, only GFPhi cells (in-
dicative of extreme BTN3A1 overexpression) displayed surface
BTN3A1 expression (Fig. 2C and Fig. S4A). Hence, BTN3A1 was
intrinsically inefficient at cell surface localization. Conversely,
BTN3A3 was more efficient at cell surface localization, whereas
BTN3A2 showed intermediate properties (Fig. 2C and Fig. S4A).
The distinct phenotypes were not a result of minor differences in
leader-peptide (LP) sequences, as swapping those across BTN3A
proteins (e.g., LP3A2-3A1, LP3A1-3A3) did not affect the signature
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Fig. 1. Requirements for BTN3 proteins for Vγ9Vδ2+ T cell responses to
PAgs. (A) Schematic domain organization of BTN3A proteins (blue, IgV; gray,
IgC; yellow, TM; red/pink B30.2 domain). (B) RT-PCR for the BTN genes listed
on the left and for GAPDH, using RNA of denoted cell lines (Upper). (C) Cell
lines listed were pulsed for 12 h with Zol (0.04–50 μM, 5× dilution steps) and
cocultured for 5 h with a polyclonal Vγ9Vδ2+ T cell line in the presence of a
CD107a antibody: results are means of duplicate stimulations, representative
of two independent experiments. (D) CRA123 cells were transfected with
pCSIGPW, either EV or encoding the indicated BTN3 proteins, single or in
combinations, before treatment with Zol and assayed for their capacity to
promote Vγ9Vδ2+ T cell degranulation as in C.
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expression patterns (Fig. S4B), which were also unaltered in Zol-
pulsed or HMBPP-pulsed cells. Surface expression of N-terminal
FLAG-tagged BTN3A1 was greatly enhanced by coexpression
with untagged BTN3A2 or BTN3A3 (Fig. 2D, Upper). Conversely,
BTN3A3 did not enhance surface BTN3A2 expression (Fig. 2D,
Middle). Consistent with its failure to coimmunoprecipitate
with BTN3A1 (Fig. 2A), BTN3A2ΔIgC did not promote surface
BTN3A1 expression (Fig. 2E). BTN3A1 surface expression was
likewise not promoted by BTN1A1, BTN2A1, BTN2A2, BTNL3,
BTNL8, or BTNL8-short (BTNL8S; Fig. S5A), further attesting
to the specificity of BTN3A protein interactions.
To independently analyze BTN3A1 expression, confocal mi-
croscopy was employed. On cells coexpressing FLAG-BTN3A1
and HA-BTN3A2ΔIgC (which cannot interact with each other),
anti-HA detected some surface expression of BTN3A2ΔIgC, but
anti-FLAG only detected BTN3A1 in permeabilized cells (Fig.
S5B). In contrast, nonpermeabilized cells coexpressing FLAG-
BTN3A1 and HA-BTN3A2 [which can complex (Fig. 2A)] stained
for both FLAG and HA, reflecting the proteins’ coexpression and
cell surface colocalization (Fig. S5B). Taken together, the data
argue that IgC-dependent interactions of BTN3A1 and BTN3A2
regulate their subcellular localization. To investigate the molecular
basis for this functional collaboration, an extended mutational
analysis was undertaken of BTN3A1 and BTN3A2, as these (un-
like BTN3A3) were each required for full PAg-dependent T cell
activation (Fig. 1C).
Motifs Within BTN3A1. CRA123 cells (lacking all BTN3A genes)
were transfected with a set of BTN3A1 chimaeras (Fig. 3A) and
assessed for surface expression and the corresponding capacity to
stimulate Vγ9Vδ2+ T cells. Relative to BTN3A1, BTN3A3 pos-
sesses an extended C terminus beyond the B30.2 domain, and
when this was added to BTN3A1 (3A1-3, Fig. 3A, purple), it
improved its surface expression (Fig. 3B). Given that the C ter-
minus can evidently modify the subcellular localization of BTN3A
proteins, we generated a chimaera fusing GFP to the C terminus
of BTN3A1 (3A1-GFP), a strategy employed by others (7, 14).
This too showed greatly increased BTN3A1 surface expression
(Fig. 3 A and B, green), suggesting caution in interpreting data
where C-terminal BTN3A fusions are used interchangeably with
wild type. Increased surface BTN3A1 expression was also achieved
by substituting the intracellular region (Gln272-Lys334) located
between the TM and B30.2 domains of BTN3A1 with the corre-
sponding region (Arg272-Ala334) of BTN3A2 (3A1/2-1; Fig. 3 A
and B, blue). When assayed for their functional potentials using a
standard concentration of Zol (5 μM), greatly increased surface
expression invariably decreased PAg-dependent Vγ9Vδ2+ T cell
activation, the most extreme example being 3A1/2-1 (Fig. 3C and
Fig. S6A). Hence, subcellular localization profoundly affected
BTN3A1 function, as is further considered here.
Because the 3A1/2-1 construct includes the BTN3A1 ectodo-
main and the B30.2 domain, including His381, its failure to drive
Vγ9Vδ2+ T cell activation implicates the region (Gln272-Lys334) as
critical for function. Indeed, placing the entire intracellular region
(Gln272-Ala513) of BTN3A1 downstream of the BTN3A2 ecto-
and TM-domains (3A2/1) fully recapitulated the signature
expression and function of BTN3A1 (Fig. 4 A–C), clearly demon-
strating that the BTN3A1 and BTN3A2 extracellular domains are
interchangeable. In contrast, a construct (3A2-1) in which just the
BTN3A1 C terminus (Ala335-Ala513), including the B30.2 domain,
was directly fused to the C terminus of BTN3A2 displayed in-
creased surface expression relative to BTN3A1, but no function
(Fig. 4 A–C), providing further evidence that BTN3A1 function
depends on intracellular determinants lying between its TM and
B30.2 domains, located between Gln272 and Lys334.
Motifs Within BTN3A2. To define BTN3A2 sequences required to
functionally collaborate with endogenous BTN3A1, we employed
CRA23 cells that express BTN3A1. Consistent with data pre-
sented earlier, functional rescue was achieved by reexpression of
BTN3A2, but not BTN3A2ΔIgC, whose gene-product cannot as-
sociate with BTN3A1 (Fig. 4 D and E and Fig. S6B). There-
upon, we focused on the relatively short intracellular domain of
BTN3A2, which lacks a B30.2 domain (Fig. 1A). Removal of
the 20 most C-terminal amino acids (3A2Δ315–334) prevented
BTN3A2 from functionally rescuing CRA23 cells, whereas trun-
cation of the last 10 amino acids (3A2Δ325–334) did not (Fig. 4 D
and E and Fig. S6B), thus establishing the importance of amino
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acids 315–324. This decamer includes KRKKIQ313–318, which in-
cludes two candidate motifs (KxK and KKxx) for ER retention/
retrieval, a quality control step influencing the export of properly
assembled protein complexes (21, 22). Of note, two different motifs
with analogous functional potentials (RWR313–315, RGER322–325;
Fig. 4F, purple) are found between the BTN3A1 TM domain (Fig.
4F, yellow) and the B30.2 domain (Fig. 4F, red) in the Gln272-Lys334
subregion, shown earlier to be functionally important. Hence, we
further investigated these motifs.
ER Association of BTN3A1 and BTN3A2. We first assessed whether
the intracellular domains of BTN3A1 and BTN3A2 did contribute
to ER retention/retrieval. FLAG-tagged BTN3A1 introduced into
CRA123 cells largely colocalized with the ER marker, protein
disulphide isomerase (PDI), but not with a Golgi marker, Gm130
(Fig. 5A), quantitated by high bright detail similarity (BDS) of
FLAG-PDI, but not of FLAG-Gm130 (Fig. 5A, Lower). Just
as BTN3A2 enhanced BTN3A1 surface expression (Fig. 2D),
BTN3A1 showed reduced ER colocalization in cells cotransfected
with BTN3A2 (Fig. 5A, orange segregation from cyan; reduced
FLAG-PDI BDS). Confocal microscopy likewise revealed that
mCherry-tagged Sec61β, another ER-resident marker, colocalized
with cotransfected BTN3A1 or BTN3A2 expressed singly, but less
so when BTN3A1 and BTN3A2 were coexpressed (Fig. 5B).
Consistent with ER association being driven by each of the
putative motifs in BTN3A1 and BTN3A2 (Fig. 4F), their non-
conservative mutation (BTN3A1: RWR313–315-RGER322–325 >
AWA-AGEA, and BTN3A2: KRKKIQ313–318 > KRAAIQ)
substantially increased the proteins’ cell surface expression,
whereas conservative R/K substitutions (RWR-RGER > KWK-
KGEK) did not, in one case exaggerating BTN3A2 retention
(KRKKIQ > KRRRIQ) (Fig. 6A).
Given that subcellular localization is critical for function, we
considered how the ER retention motifs might affect the pro-
teins’ functional collaboration. If expressed with either wild-type
BTN3A2 (KRKKIQ) or a KRRRIQ mutant, both of which
strongly associate with the ER (Fig. 6A), nonconservative mu-
tation of BTN3A1 RWR313–315-RGER322–325 to AWA-AGEA
did not limit functional collaboration, whereas it impaired
functional collaboration with the KRAAIQ mutant (Fig. 6 B and
C, purple box and arrow; Fig. 6D). Conversely, rescue of the
BTN3A1 AWA-AGEA mutant was not significantly reduced
by nonconservative mutations of the putative KRK312–314 motif
(e.g., KRKKIQ > AAKKIQ; Fig. S7). Of note, the BTN3A2-
KRAAIQ mutant could still collaborate with either BTN3A1
(WT, RWR-RGER) or the conservative KWK-KGEK mutant
(Fig. 6 B–D). These data demonstrate complementation,
whereby function requires an ER retention motif or motifs in at
least one of BTN3A1 or BTN3A2, consistent with the active
functional unit being a heteromer with strictly regulated sub-
cellular trafficking. Indeed, it was again the case that some
BTN3A1/BTN3A2 mutant pairings (e.g., 3A1-KWK-KGEK+
3A2-KRRRIQ) were functional despite decreased cell surface
expression (Fig. 6B, Right and Fig. 6 C and D).
Conserved ER Retention of BTNL/Btnl Proteins.Given the importance
of regulated subcellular localization and ER associations for
BTN3A1-BTN3A2 collaboration, we examined whether similar
properties might underpin Btnl1-Btnl6 and BTNL3-BTNL8 col-
laborations. After transfection of 293T cells that do not ordinarily
express these four proteins, all showed strong PDI colocalization
(Fig. S8 A–D). Moreover, Btnl1/Btnl6 coexpression reduced PDI
colocalization (Fig. S8 A and B), as was observed for BTN3A2-
BTN3A1 collaboration (Fig. 5A). Although this was a priori less
apparent for BTNL3/BTNL8 coexpression (Fig. S8 C and D), the
effect of coexpression became clearer when asking whether
a protein sat within or outside of a “mask” defined by PDI
expression: clearly BTNL3/BTNL8 coexpression increased the
fraction of protein outside the mask, albeit to a lesser extent
than Btnl1/Btnl6 coexpression (Fig. S9A). Consistent with this,
BTNL8 coexpression increased BTNL3 surface expression (Fig.
S9B; compare the green histograms). In sum, all BTN(L)/Btnl
proteins implicated in specific γδ subset regulation displayed
hallmarks of preferential ER association that were diminished by
coexpression of their functionally relevant partners.
Further Functional BTN/BTNL/Btnl Conservation. Finally, another
short subregion between the TM and B30.2 domains of BTN3A1
(YNEWKKALFKPA), recently found to be functionally impor-
tant (23), is centered on an EWK motif that we also found to be
functionally indispensable for Vγ9Vδ2+ cell activation (Fig.
S9C). However, it was unaffected by mutation to DWR, which is
conserved similarly close to the B30.2 domains of BTNL3,
BTNL8, Btnl1, and Btnl6 (Fig. S9D), providing further indica-
tions of conservation of mechanism.
Discussion
This study has provided many insights into how BTN and BTNL
proteins regulate γδ cell biology. First, CR-mediated gene deletion
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(rather than shRNA knock-down) provided unequivocal evidence
that specifically disrupting BTN3A2 profoundly impaired the ca-
pacity to mediate PAg-dependent Vγ9Vδ2+ T cell activation.
Moreover, BTN3A2 could be stoichiometrically coimmunopreci-
pated with BTN3A1, consistent with their forming heteromeric
complexes. Although the requirement for BTN3A2 was not absolute,
this likely reflected partial compensation by BTN3A3, which could
also be coimmunoprecipitated with BTN3A1. Indeed, BTN3A1+
cells lacking BTN3A2 and BTN3A3 showed no residual functional
activity. Moreover, in experiments in which the functional potentials
of BTN3A-null CRA123 cells were rescued with BTN3 genes, po-
tencies (Emax) comparable to wild-type cells were achieved only
when BTN3A1 was expressed with BTN3A2 and/or BTN3A3.
Nonetheless, because BTN3A3 was not ordinarily required for
Vγ9Vδ2+ T cell activation in cells expressing BTN3A1 and BTN3A2,
this study has focused on BTN3A1 and BTN3A2 cooperation.
Optimal Vγ9Vδ2+ T cell responses to a range of Zol concen-
trations depended on the BTN3A2-IgC domain required for
BTN3A2 to interact with BTN3A1, thereby linking complex for-
mation with function. Complex formation was also linked to in-
creased BTN3A1 cell surface expression, although this alone could
not explain functional collaboration, as unrestricted surface ex-
pression habitually decreased function. Instead, functionally im-
portant domains were mapped to intracellular regions of BTN3A1
and BTN3A2 that regulated the proteins’ association with the ER.
This may have been overlooked by studies employing GFP-fusion
proteins because BTN3A1 proteins with altered C-termini can
show atypical subcellular localization. In contrast, the importance
of ER association was highlighted by a clear instance of functional
complementation in which optimal Vγ9Vδ2+ T cell stimulation
requires ER retention motifs in either BTN3A1 or BTN3A2 but
not both. This is most readily explained by the bioactive unit being
a physically associated BTN3A1-3A2 heteromer.
Thus, we propose a model whereby the BTN3A1 ectodomain
and B30.2-domains are active entities in Vγ9Vδ2+ cell stimula-
tion, with which BTN3A2 collaborates by regulating the appro-
priate routing, kinetics, and/or stability of BTN3A1. This may
include a critical “dwell time” in the ER, mediating a quality
control step for multimer formation, and/or permitting interaction
with other moieties (e.g., cargo). Of note, sterol metabolism,
which BTN3A1 may monitor via isopentenylpyrophosphate
binding, involves ER-resident enzymes of the mevalonate pathway
that are regulated by sterol regulatory element-/binding protein
factors whose inactive forms also reside in the ER (24). Possibly,
the BTN3A1-3A2 heteromers promote ER exit by masking the
ER retention motifs, as has been reported in other systems (25).
The partial rescue of CRA123 cells by BTN3A1 likely reflects
some capacity of overexpressed homomeric BTN3A1 to exit the
ER without BTN3A2/BTN3A3, but its suboptimal routing, ki-
netics, and/or stability result in suboptimal EC50, and possibly
reduced Emax. Likewise, the model predicts the observed func-
tional deficits of constructs that accelerate surface expression at
the expense of ER association. Of note, BTN3A1 lacks the extended
C-terminal sequences of BTN3A3 that promote efficient cell surface
BTN3A3 expression.
Our study also establishes parallels of BTN3A1/BTN3A2 bi-
ology with Btnl1/Btnl6 and BTNL3/BTNL8 that respectively reg-
ulate murine and human gut γδ cells. In each case, optimal
function required pairs of proteins that intrinsically displayed ER
association, thereby limiting cell surface expression until coex-
pressed (19). Furthermore Skint1, on which murine Vγ5+ intra-
epidermal T cells depend, also shows poor surface expression and
is functionally ablated by constructs that drive it to the cell surface
(26). Hence, our current study emphasizes conserved cellular and
molecular mechanisms that may underpin γδ cell regulation across
mouse and human, and across peripheral tissues and blood. This is
a major departure from the long-held view that human lymphoid
γδ cells and murine tissue-resident γδ cells are broadly dissimilar.
Nonetheless, each subtype of γδ cell regulation may have unique
signatures. In particular, no equivalent of PAgs has been identified
for BTNL/Btnl-dependent gut γδ cells or for Skint1-dependent
murine skin γδ cells. Conversely, although no broadly accepted ev-
idence currently exists that BTN3A1-3A2 present PAg cargo to γδ
T cells, our model for BTN3A1-3A2 function has possible parallels
with ER dwell times required for CD1d, MHC-I, and MR1 proteins
to acquire low-molecular-mass lipid, peptide, and vitamin B me-
tabolite cargoes, respectively. Indeed, those cargoes stabilize the
proteins and regulate their cell-surface display to T cells (27–29).
Moreover, the actions of different BTN/BTNL gene products may
also have parallels with antigen activation of human T cells by MHC
class II DQ and DR molecules, for which the closely related mol-
ecules, DO and DM, are not absolutely required, but are important
in regulating the quality of antigen presentation.
Materials and Methods
All reagents, cells, culture conditions, plasmids, and primers are listed in the SI
Materials and Methods.
Generation of CR Lines, Cloning, and RT-PCR. Targeting sequences were cloned
using short complementary oligos (Table S1). 293T CR lines were generated
by transient transfection of pLG2C and single-cell sorting on the basis of GFP
expression at 72 h. Tagged constructs were generated by overlapping PCR
except mCherry-Sec61β (gift from Professor Martin-Serrano, KCL). Murine
FLAG-Btnl1 and HA-Btnl6 and human FLAG-BTNL3 and FLAG-BTNL8 were
described (19). Wild-type BTN1A1, BTN2A1, BTN2A2, BTN3A1, BTN3A2, and
BTN3A3 were cloned from 293T cells, and wild-type BTNL3, BTNL8S, and
BTNL8 from Caco-2 cells (primers in Table S2). Gene expression was checked
by RT-PCR, using the same primers.
Flow Cytometry, Confocal Microscopy, and Image Cytometry. 293T cells were
seeded at 0.5 × 105 per well in 12-well plates and transfected the next day
with 1 μg total plasmid DNA before expression assessment by flow, confocal
imaging, and image cytometry.
Flow Cytometry. Cells were washed in FACS buffer (FB; PBS, 5% FCS), stained
with the indicated antibodies (45 min, 4 °C), washed twice, and resuspended
in FB. Data were acquired on a FACSCanto II (BD) and analyzed in FlowJo.
For intracellular staining, see following.
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Fig. 6. ER association of BTN3 is critical for its
function. (A) CRA123 cells were transfected with the
indicated WT or ER-retention motif mutants of
BTN3A1 (Upper) and BTN3A2 (Bottom), and cell
surface expression assessed by flow cytometry.
Representative of three independent transfections.
(B) CRA123 cells were cotransfected with the in-
dicated constructs before treatment with 5 μM Zol.
Cell surface BTN3A expression was monitored and
(C) the functional potential of the transfectants
measured as described for Fig. 4. Data are the mean
of three stimulations ± SD. Representative of three
independent experiments. P values are relative to
the combination of WT BTN3A1+BTN3A2. Purple arrow in C denotes functional deficiency of cells whose BTN3A expression is shown in purple-boxed plot
in B. (D) CRA123 cells were transfected with pCSIGPW, either as an EV or encoding indicated BTN3 WT or ER motif mutants before a 12-h treatment with
Zol (0.04–50 μM, 5× dilution steps) and assayed for their capacity to promote Vγ9Vδ2+ T cell degranulation. Data points are the mean of duplicate
stimulations and representative of two independent experiments.
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Confocal Microscopy. Cells were transferred 24 h posttransfection onto 13-mm
glass coverslips, left to adhere for 24 h (37 °C, 5% CO2), washed with PBS and
fixed with CellFix buffer (BD), permeabilized (or not) with permeabilization/wash
buffer (PWB; eBioscience), stained in FB (surface) or PWB (intracellular), and
washed twice in FB or PWB and then twice in FB. Coverslips were mounted using
Prolong Gold (Thermo Fisher). Data were acquired on a TCS SP2 AOBS micro-
scope (HCX PL APO CS 63.0×/1.4 oil objective; Leica) and analyzed in ImageJ.
Image Cytometry. Cells were fixed and permeabilized and stained in PWB
supplemented with DAPI. Data were acquired on an ImageStreamX (Merck
Millipore) and analyzed in IDEAS. Data were analyzed in IDEAS, and histo-
grams generated in R.
CD107a Assay. Briefly, 293T cells (24 h posttransfection when relevant) were
pretreated or not for 12 h with HMBPP or Zol, washed twice in DMEM,
coincubated for 5 h with Vγ9Vδ2+ T cells (3:1 ratio) and PE anti-CD107a
antibody (1 μg/mL) in RPMI complete media (37 °C, 5% CO2), washed with FB
and stained with AlexaFluor647 anti-CD3 and FITC anti-TCRVδ2, and washed
twice and resuspended in FB for acquisition (30).
Coimmunoprecipitation and Western Blotting. 293T cells were seeded at 1 ×
106 per well in six-well plates, transfected the next day with 2 μg total
plasmid DNA, washed in PBS 48 h posttransfection, and harvested in 0.5 mL
lysis buffer [50 mM Tris·HCl at pH 7.4, 150 mM KCl, 10 mM MgCl2, 1 mM
CaCl2, 0.5% Nonidet P-40, 0.1% digitonin, 5% glycerol, Complete Protease
inhibitor (Roche Diagnostics)]. Lysates were clarified at 12,000 × g (4 °C,
5 min), 50 μL mixed with Laemmli buffer, and boiled for input analysis.
Remaining lysates were incubated for 4 h at 4 °C on a rotating wheel with
50 μL protein G Dynabeads (Thermo Fisher) preincubated with anti-FLAG
antibody and washed three times in lysis buffer. Proteins were eluted in 30 μL
Laemmli and analyzed by SDS/PAGE and Western blotting. Blots were visu-
alized by ImageQuant using HRP-anti-HA (3F10; Roche) and HRP-anti-FLAG
(M2; Sigma), and by Li-cor Odyssey imaging using rabbit anti-HSP90 (H-114;
Santa Cruz Biotechnology) and IRDye680LT anti-rabbit antibodies (Li-cor).
Mass Spectrometry. Anti-FLAG immunoprecipitation (Coimmunoprecipita-
tion and Western Blotting) was performed on 5 × 106 CRA123 cells trans-
duced with an empty vector control (EV), FLAG-BTN3A1+HA-BTN3A2, and
FLAG-BTNL3+HA-BTNL8. Eluted proteins were subjected to SDS/PAGE until
the running front had migrated 1 cm into the gel. Proteins were in-gel
digested using trypsin, and peptides were analyzed with an Orbitrap-Fu-
sion Lumos mass spectrometer coupled to an Ultimate3000 HPLC equipped
with an EASY-Spray nanosource (Thermo Fisher Scientific). Raw data for
triplicate runs were processed using MaxQuant v1.6.0.1, using label-free
quantification (MaxLFQ) selected as the quantification algorithm. The
proteingroup.txt output table was imported into Perseus software for
further processing. LFQ intensities were log2 transformed, and the dataset
was filtered for proteins having at least three values in at least one group
(each group consisting of triplicate injections). The remaining missing
values were imputed using default Perseus settings by drawing from a
simulated noise distribution with a down shift of 1.8 and a width of
0.3 compared with the log2 LFQ intensity distribution. Two-sample Welch
t tests were performed with a permutation-based FDR set at 0.05.
Statistics. Data were analyzed using unpaired two-tailed Student’s t test.
Reference datasets used to determine significance are indicated in each case.
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